¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Ç¥"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
  • Papanicolaou smear
    ÆÄÆÄ´ÏÄÝ·ÎÆì¹Ù¸¥Ç¥º»
  • postaxial phocomelia
    ÃàµÚ¹Ù´ÙÇ¥¹ü¹ßÁõ, ÃàµÚ´Ù¸®ÂªÀºÁõ
  • postsynaptic neuron
    ½Ã³À½ºÀÌÈĽŰ漼ǥ, ¿¬Á¢ÀÌÈĽŰ漼Æ÷
  • preparation
    1. Áغñ 2. ¾àÁ¦, Á¦Àç 3. Á¶Á÷Ç¥º»
  • probability graph
    È®·üµµÇ¥
  • probability sample
    È®·üÇ¥º»
  • pseudoisochromatic plate
    À¯»çµî»ö¼ºÆÇ, °¡¼ºµ¿»öÇ¥
  • pulmonary surfactant
    ÆóÇ¥¸éȰ¼ºÁ¦, ÇãÆÄÇ¥¸éȰ¼ºÁ¦
  • parameter
    1. ÁöÇ¥, ¸Å°³º¯¼ö, ÆÄ¶ó¹ÌÅÍ 2. °æ¼ö, ¸ð¼ö
  • parametric
    1. ÀÚ±ÃÁÖÀ§- 2. ÁöÇ¥-
  • parametric test
    ÁöÇ¥°ËÁ¤
  • percent labeled mitosis technique
    ¹éºÐÀ²Ç¥ÁöÀ¯»çºÐ¿­¹ý
  • periderm
    1. žÆÇ¥ÇÇ 2. ¹Ù±ùÇ¥ÇÇ
  • peripheral blood smear
    ¸»ÃÊÇ÷¾×Æì¹Ù¸¥Ç¥º»
  • permanent preparation
    ¿µ±¸Ç¥º»
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
  • epidermotrophism
    Ç¥ÇÇÁöÇâ
  • epidermotrophic reticulosis
    Ç¥ÇÇÁöÇâ±×¹°Áõ, Ç¥ÇÇÁöÇâ¼¼¸ÁÁõ
  • epidermatomycosis
    Ç¥ÇÇÁø±ÕÁõ
  • interface dermatitis
    Ç¥ÇÇÁøÇǰæ°è¸éÇǺο°
  • exfoliative toxin
    Ç¥ÇÇÅ»¶ôµ¶¼Ò
  • transepidermal elimination
    Ç¥ÇÇÅë°úÁ¦°Å
  • surface mold
    Ç¥ÇÇÆ², Ç¥ÇÇÁÖÇü
  • Staphylococcus epidermidis
    Ç¥ÇÇÆ÷µµ¾Ë±Õ
  • epidermal inclusion cyst
    Ç¥ÇÇÆ÷ÇÔ³¶
  • epidermopoiesis
    Ç¥ÇÇÇü¼º
  • epidermal dysplasia
    Ç¥ÇÇÇü¼ºÀÌ»ó
  • epidermodysplasia
    Ç¥ÇÇÇü¼ºÀÌ»ó
  • expression
    Ç¥Çö, ¹ßÇö
  • expressivity
    Ç¥Çöµµ
  • expressive skill
    Ç¥Çö·Â, Ç¥Çö±â¼ú
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
  • surface law
    üǥ¸é¹ýÄ¢
  • trace labeling
    ÃßÀûÇ¥Áö
  • manifestation
    ¼Ò°ß, Ç¥Çö, Ç¥½Ã
  • milestone
    ÀÌÁ¤Ç¥
  • monomeric
    ´ÜÀÎÀÚÇ¥Çö-
  • mucoepidermoid
    Á¡¸·Ç¥ÇǸð¾ç-
  • maximum surgical blood order schedule
    ÃÖ´ë¼ö¼úÇ÷¾×¿äû°èȹǥ, ÃÖ´ë¼ö¼úÇ÷¾×½Åû·®
  • microbiologic marker
    ¹Ì»ý¹°ÇÐÀûÇ¥ÁöÀÚ
  • molecular marker
    ºÐÀÚÇ¥ÁöÀÚ
  • multitarget model
    ´ÙÇ¥Àû¸ðµ¨
  • multitarget multihit model
    ´ÙÇ¥Àû´ÙÀûÁ߸ðµ¨
  • multitarget single hit model
    ´ÙÇ¥Àû´ÜÀÏÀûÁ߸ðµ¨
  • risk marker
    À§Ç赵ǥÁö
  • role model
    ¿ªÇÒÇ¥º»Çü
  • tumor marker
    Á¾¾çÇ¥ÁöÀÚ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
  • leptocytes = target cell
    Ç¥Àû»óÀûÇ÷±¸= Ç¥Àû¼¼Æ÷
  • leptocytosis
    Ç¥Àû»óÀûÇ÷±¸Áõ°¡Áõ(?Ì¡?Ì¡).
  • leptocytosis
    Ç¥Àû»óÀûÇ÷±¸Áõ°¡Áõ(¡­ñòÊ¥ñø).
  • target glands
    Ç¥Àû¼±(øöîÜàÍ).
  • cell, target
    Ç¥Àû¼¼Æ÷
  • codocyte= target cell
    Ç¥Àû¼¼Æ÷
  • target cell
    Ç¥Àû¼¼Æ÷
  • targetoid hemosiderotic hemangioma
    Ç¥Àû¾ç Çì¸ð½Ãµ¥¸° Ç÷°üÁ¾
  • target theory
    Ç¥ÀûÀÌ·Ð
  • target organ
    Ç¥ÀûÀå±â
  • critical organ
    Ç¥ÀûÀå±â, À§ÇØÀå±â
  • target cell anemia
    Ç¥ÀûÀûÇ÷?úÔºóÇ÷(øöîÜ îåúìϹàõÞ¸úì)
  • target cell anemia
    Ç¥ÀûÀûÇ÷±¸¼º ºóÇ÷(øöîÜ îåúìϹàõÞ¸úì).
  • target tissue
    Ç¥ÀûÁ¶Á÷(øöîÜðÚòÄ)
  • target skin distance=TSD
    Ç¥ÀûÇǺΰŸ®
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
  • electron bleaching
    ÀüÇØÇ¥¹é(ï³ú°ø÷ÛÜ).
  • electron microscopic autoradiography
    µ¿À§¿ø¼ÒÇ¥Áö ÀüÀÚÇö¹Ì°æ¹ý
  • emotion, expressed(EE)
    Ç¥Ãâ°¨Á¤
  • encephalitis haemorrhagica superior<³ª>
    Ç¥À缺 ÃâÇ÷¼º ³ú¿°.
  • endometrial aspiration smear
    Àڱ󻸷ÈíÀεµ¸»Ç¥º»(¡­ÓóØÆøöÜâ).
  • endometriosis cutaneus
    Ç¥À缺 Àڱ󻸷Áõ.
  • enzyme label(l)ing
    È¿¼ÒÇ¥Áö.
  • enzyme labeled antibody
    È¿¼ÒÇ¥ÁöÇ×ü.
  • enzyme labelling
    È¿¼ÒÇ¥Áö
  • epicranial muscle<³ª> musculus epicranius
    ¸Ó¸®µ¤°³±Ù, µÎ°³Ç¥±Ù(ÔéËÏøúÐÉ).
  • epiderm = epidermis
    Ç¥ÇÇ(øúù«)
  • epiderm =epidermis
    Ç¥ÇÇ(øúù«).
  • epidermabrasion
    Ç¥ÇÇ ¹ÚÇǼú
  • epidermal
    Ç¥ÇǼº(øúù«àõ)ÀÇ
  • epidermal abundance
    Ç¥Çǰú´Ù
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 11
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
  • T32.7
    Corrosions involving 70-79£¥ of body surface
    ½Åüǥ¸éÀÇ 70-79£¥¸¦ Æ÷ÇÔÇÑ ºÎ½Ä
  • T32.8
    Corrosions involving 80-89£¥ of body surface
    ½Åüǥ¸éÀÇ 80-89£¥¸¦ Æ÷ÇÔÇÑ ºÎ½Ä
  • T32.9
    Corrosions involving 90£¥ or more of body surface
    ½Åüǥ¸éÀÇ 90£¥ ÀÌ»óÀ» Æ÷ÇÔÇÑ ºÎ½Ä
  • T95.4
    Sequelae of burn and corrosion classifiable only according to extent of body surface involved
    ħ¹üµÈ ½Åüǥ¸éÀÇ Á¤µµ¿¡ µû¶ó¼­¸¸ ºÐ·ù °¡´ÉÇÑ È­»ó ¹× ºÎ½ÄÀÇ ÈÄÀ¯Áõ
  • Z60.5
    Target of perceived adverse discrimination and persecution
    À¯ÇØÇÑ Â÷º° ¹× ¹ÚÇØ¸¦ ¹Þ´Â ¸ñÇ¥¹°
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • safty standard
    ¾ÈÀü Ç¥ÁØ
  • sample design
    Ç¥º» ¼³°è
  • sample preservation
    Ç¥º» º¸Á¸
    µµ¸» ÈÄ »¡¸® ¿°»öÇÏ¿© º¸Á¸ÇÏ´Â °ÍÀ¸·Î¼­, ½Ã°£ÀÌ °æ°úÇÏ¸é ¿°»ö¼ºÀÌ ÀúÇϵȴÙ.
  • sampling error
    Ç¥º» ¿ÀÂ÷
    Ç¥º» µ¥ÀÌŸ·ÎºÎÅÍ °è»êµÈ ¸ð¼ö ÃßÁ¤Ä¡¿Í ¸ð¼öÀÇ Â÷ÀÌ.
  • sampling inspection
    Ç¥º» ÃßÃâ °Ë»ç
  • sampling number
    Ç¥º» ÃßÃâ ¼ö
  • scalded skin syndrome
    Ç¥ÇÇ ¹Ú¸® ÁõÈıº
    Ȳ»ö Æ÷µµ ±¸±ÕÀÇ Ç¥ÇÇ ¹Ú¸® µ¶¼Ò¿¡ ÀÇÇÑ ÇǺκ´À¸·Î, ÀÌ ÁúȯÀÇ ÀÓ»ó Áõ»óÀº ÀÌ µ¶¼Ò¿¡ ±âÀÎÇϸç Ȳ»ö Æ÷µµ ±¸±Õ °¨¿° ±× ÀÚü¿¡ ÀÇÇÑ ¿µÇâ°ú´Â ±¸ºÐµÈ´Ù. 3°¡Áö ÀÓ»óÀû Áõ»óÀ¸·Î´Â, Àü½Å¼º Ç¥¸® ¹Ú¸®¼º ÇǺο°, Bullous im
  • scheme
    °èȹ, µµÇ¥, µµ½Ä
  • smeary
    µµ¸» Ç¥º»ÀÇ
  • specimen
    °Ëü, Ç¥º», °Ë»ç¹°
    1. ¿äÀÇ °Ëü¿Í °°ÀÌ ÀüüÀÇ ¼ºÁúÀ» ³ªÅ¸³»°Å³ª ¶Ç´Â °áÁ¤Çϱâ À§Çؼ­ äÃëÇÑ ÇÑ °³ ¶Ç´Â ¿©·¯ °³ ¹°ÁúÀÇ Ç¥º». 2. º´¸®ÇÐÀû °Ë»ç¸¦ À§ÇÑ Á¶Á÷Ç¥º» ¶Ç´Â ±× ±¸Á¶¸¦ ¿¬±¸Çϱâ À§ÇÑ Á¤»ó Á¶Á÷. ±â°ü ¶Ç´Â ¼¼±ÕÀÇ Ç¥º».
  • standard
    Ç¥ÁØ, ±âÁØ
  • standard consistency
    Ç¥ÁØ Á¡Á¶µµ
  • standard dosing :

    standard error

    Ç¥ÁØ ¿ÀÂ÷
  • standard illuminant
    Ç¥ÁØ ±¤¿ø
    »ó´ëÀûÀÎ Èû ºÐ»ê °î¼±ÀÇ ¿ë¾î·Î CIE¿¡ ÀÇÇØ A,B,C,D·Î Á¤ÀǵǴ ±¤¿ø.
  • standard light source
    Ç¥ÁØ ±¤¿ø
    ½ºÆåÆ®·³ ºÐ»ê·ÂÀÌ ¾Ë·ÁÁø ±âÁØ ±¤¿ø.
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 12 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
  • expression
    Ç¥Çö,¹ßÇ¥,Ç¥Á¤
  • representation
    Ç¥Çö; ÁÖÀå; Ç×ÀÇ; ´ëÇ¥´Ü
  • expression
    Ç¥Çö;¸»Åõ;Ç¥Á¤
  • unexpressive
    Ç¥Çö·ÂÀÌ ºÎÁ·ÇÑ;¶æÀ» ÃæºÐÈ÷ Àü´ÞÇÏÁö ¸øÇÏ´Â
  • phenetics
    Ç¥Çö·ÐÀû ºÐ·ù !
  • expressional
    Ç¥Çö»óÀÇ;Ç¥Á¤ÀÇ
  • expressionism
    Ç¥ÇöÁÖÀÇ;Ç¥Çö°ú
  • expressionistic
    Ç¥ÇöÁÖÀÇÀûÀÎ
  • expressive
    Ç¥ÇöÇÏ´Â;ÀÇ¹Ì ½ÉÀåÇÑ;Ç¥Á¤ÀÌ Ç³ºÎÇÑ;Ç¥ÇöÀÇ
  • express
    Ç¥ÇöÇÏ´Ù;Ç¥½ÃÇÏ´Ù;Áö±ÞÆíÀ¸·Î º¸³»´Ù;¸í½ÃµÈ;¸í¹éÇÑ;Á¤È®ÇÑ;Ưº°ÇÑ;±ÞÇàÀÇ;Áö±ÞÆíÀÇ;¿î¼ÛÆíÀÇ;Ưº°È÷;±ÞÇàÀ¸·Î;¼Ó´Þ·Î;Áö±ÞÆí;Ưº°Æí;±ÞÇà¿­Â÷;¿î¼Ûȸ»ç
  • expressible
    Ç¥ÇöÇÒ ¼ö ÀÖ´Â;Â¥³¾ ¼ö ÀÖ´Â
  • phenotype
    Ç¥ÇöÇü;ȯ°æ¿¡ µû¶ó ¿ÜºÎ¿¡ ³ªÅ¸³ª´Â
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
  • wellturned
    ±³¹¦È÷ Ç¥ÇöµÈ
  • yardstick
    Ç¥ÁØ
  • -er
    (µ¿»ç¿Í ¸í»ç¿¡¼­ µ¿ÀÛÀÚ)¸í»ç¸¦ ¸¸µë;...ÇÏ´Â °Í;¹Ýº¹À» Ç¥½ÃÇÏ´Â µ¿»ç¸¦ ¸¸µê
  • Addressograph
    =ADDRESSING MACHINE(»óÇ¥¸í)
  • All American
    Àü¹Ì´ëÇ¥ÀÇ;¹Ì±¹ÀÎÀ¸·Î¸¸ µÈ;¹Ì±¹Á¦ÀÏÀÇ(»ç¶÷)
  • Amytal
    ¾Æ¹ÌÅ»(ÁøÁ¤Á¦,»óÇ¥¸í)
  • Antiphlogistine
    ¼Ò¿°°í(»óÇ¥¸í)
  • Argyrol
    ÇÔÀº¾×;¹æºÎ¿ëÀ¸·Î »ç¿ë;»óÇ¥¸í
  • Atticism
    ¾ÆÅ׳×ÀÎ ¾ÖÈ£;¾ÆÅ×³× ¹®ÇÐÀÇ Æ¯Áú;¾ÆÅ×³× Æ¯À¯ÀÇ ¸»;°£°áÇÏ°í ¿ì¾ÆÇÑ Ç¥Çö
  • Aunt Sally
    ÆÄÀÌÇÁ¸¦ ¶³¾î¶ß¸®´Â ³îÀÌ;Ç¥Àû
  • Banthine
    ¹ê½Å(À§±Ë¾ç Ä¡·áÁ¦,»óÇ¥¸í)
  • Barrie
    ¹è¸® Sir James M;~(1860-1937)(¿µ±¹ÀÇ ¼Ò¼³°¡,±ØÀÛ°¡,´ëÇ¥ÀÛ Peter Pan)
  • Benlate
    º¥·¹ÀÌÆ®(»ì±Õ¿ë ³ó¾à,»óÇ¥¸í)
  • Big Board
    ´º¿å Áõ±Ç °Å·¡¼Ò(»óÀåÀÇ ÁÖ½Ç ½Ã¼¼Ç¥)
  • Black Panther
    °ËÀº Ç¥¹ü(¹Ì±¹ÀÇ ÈæÀÎ °ú°ÝÆÄ ´ç¿ø)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 11
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 11
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
ÅëÇÕ°Ë»ö ¿Ï·á